These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9834209)

  • 1. Congenital erythropoietic porphyria successfully treated by allogeneic bone marrow transplantation.
    Tezcan I; Xu W; Gurgey A; Tuncer M; Cetin M; Oner C; Yetgin S; Ersoy F; Aizencang G; Astrin KH; Desnick RJ
    Blood; 1998 Dec; 92(11):4053-8. PubMed ID: 9834209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetics of congenital erythropoietic porphyria.
    Desnick RJ; Glass IA; Xu W; Solis C; Astrin KH
    Semin Liver Dis; 1998; 18(1):77-84. PubMed ID: 9516681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Allogeneic bone marrow transplantation in congenital erythropoietic porphyria. Gunther's disease].
    Lagarde C; Hamel-Teillac D; De Prost Y; Blanche S; Thomas C; Fischer A; Nordmann Y; Ged C; De Verneuil H
    Ann Dermatol Venereol; 1998 Feb; 125(2):114-7. PubMed ID: 9747227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of congenital erythropoietic porphyria using matched unrelated hematopoietic stem cell transplantation.
    Martinez Peinado C; Díaz de Heredia C; To-Figueras J; Arias-Santiago S; Nogueras P; Elorza I; Olivé T; Bádenas C; Moreno MJ; Tercedor J; Herrero C
    Pediatr Dermatol; 2013; 30(4):484-9. PubMed ID: 23557135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful match-unrelated donor bone marrow transplantation for congenital erythropoietic porphyria (Günther disease).
    Dupuis-Girod S; Akkari V; Ged C; Galambrun C; Kebaïli K; Deybach JC; Claudy A; Geburher L; Philippe N; de Verneuil H; Bertrand Y
    Eur J Pediatr; 2005 Feb; 164(2):104-7. PubMed ID: 15703981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Congenital erythropoeietic porphyria treated by haematopoietic stem cell allograft].
    Lebreuilly-Sohyer I; Morice A; Acher A; Dompmartin A; Clement C; de Verneuil H; Ged C; Leroy D; Verneuil L
    Ann Dermatol Venereol; 2010 Oct; 137(10):635-9. PubMed ID: 20932444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital erythropoietic porphyria: prolonged high-level expression and correction of the heme biosynthetic defect by retroviral-mediated gene transfer into porphyric and erythroid cells.
    Kauppinen R; Glass IA; Aizencang G; Astrin KH; Atweh GF; Desnick RJ
    Mol Genet Metab; 1998 Sep; 65(1):10-7. PubMed ID: 9787090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of mutations in the uroporphyrinogen III synthase gene in a Thai girl patient with congenital erythropoietic porphyria.
    Glomglao W; Treesucon A; Roothumnong E; Thongnoppakhun W; Siraprapapat P; Suwanthol L; Sanpakit K; Tanphaichitr VS
    Int J Lab Hematol; 2015 Apr; 37(2):e44-7. PubMed ID: 25092523
    [No Abstract]   [Full Text] [Related]  

  • 9. An Atypical Case of Congenital Erythropoietic Porphyria.
    Sudrié-Arnaud B; Legendre M; Snanoudj S; Pelluard F; Bekri S; Tebani A
    Genes (Basel); 2021 Nov; 12(11):. PubMed ID: 34828434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Very Early Diagnosis and Management of Congenital Erythropoietic Porphyria.
    Desjardins MP; Naccache L; Hébert A; Auger I; Teira P; Pelland-Marcotte MC
    Clin Pediatr (Phila); 2023 Jun; 62(5):399-403. PubMed ID: 36217751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital erythropoietic porphyria and erythropoietic protoporphyria: Identification of 7 uroporphyrinogen III synthase and 20 ferrochelatase novel mutations.
    Weiss Y; Balwani M; Chen B; Yasuda M; Nazarenko I; Desnick RJ
    Mol Genet Metab; 2019 Nov; 128(3):358-362. PubMed ID: 30454868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital erythropoietic porphyria: Recent advances.
    Erwin AL; Desnick RJ
    Mol Genet Metab; 2019 Nov; 128(3):288-297. PubMed ID: 30685241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALAS2 acts as a modifier gene in patients with congenital erythropoietic porphyria.
    To-Figueras J; Ducamp S; Clayton J; Badenas C; Delaby C; Ged C; Lyoumi S; Gouya L; de Verneuil H; Beaumont C; Ferreira GC; Deybach JC; Herrero C; Puy H
    Blood; 2011 Aug; 118(6):1443-51. PubMed ID: 21653323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital erythropoietic porphyria: identification and expression of eight novel mutations in the uroporphyrinogen III synthase gene.
    Shady AA; Colby BR; Cunha LF; Astrin KH; Bishop DF; Desnick RJ
    Br J Haematol; 2002 Jun; 117(4):980-7. PubMed ID: 12060141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uroporphyrinogen III synthase knock-in mice have the human congenital erythropoietic porphyria phenotype, including the characteristic light-induced cutaneous lesions.
    Bishop DF; Johansson A; Phelps R; Shady AA; Ramirez MC; Yasuda M; Caro A; Desnick RJ
    Am J Hum Genet; 2006 Apr; 78(4):645-58. PubMed ID: 16532394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of congenital erythropoietic porphyria: mutations in the human uroporphyrinogen III synthase gene.
    Xu W; Astrin KH; Desnick RJ
    Hum Mutat; 1996; 7(3):187-92. PubMed ID: 8829650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital erythropoietic porphyria.
    To-Figueras J; Erwin AL; Aguilera P; Millet O; Desnick RJ
    Liver Int; 2024 Aug; 44(8):1842-1855. PubMed ID: 38717058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of severe congenital erythropoietic porphyria by bone marrow transplantation.
    Harada FA; Shwayder TA; Desnick RJ; Lim HW
    J Am Acad Dermatol; 2001 Aug; 45(2):279-82. PubMed ID: 11464191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A knock-in mouse model of congenital erythropoietic porphyria.
    Ged C; Mendez M; Robert E; Lalanne M; Lamrissi-Garcia I; Costet P; Daniel JY; Dubus P; Mazurier F; Moreau-Gaudry F; de Verneuil H
    Genomics; 2006 Jan; 87(1):84-92. PubMed ID: 16314073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene transfer of the uroporphyrinogen III synthase cDNA into haematopoietic progenitor cells in view of a future gene therapy in congenital erythropoietic porphyria.
    Mazurier F; Moreau-Gaudry F; Salesse S; Barbot C; Ged C; Reiffers J; de Verneuil H
    J Inherit Metab Dis; 1997 Jun; 20(2):247-57. PubMed ID: 9211197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.